Trial intelligence / Profile preview

Phase IIa randomized study of GSK1278863 in anemia associated with chronic kidney disease

2012-004050-29Phase 2Completed

Sponsor
GSK
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of daprodustat in anemia of renal disease, chronic kidney disease (CKD), sponsored by GSK. Started Oct 2012; status: completed.

02

Drugs

daprodustat
03

Conditions

anemia of renal diseasechronic kidney disease (CKD)

Beyond the preview

Go deeper on 2012-004050-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004050-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call